Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

The clinical nurse specialist in uro-oncology is undervalued and underdeveloped, according to a discussion paper on the role of this clinician.

David Sallman, MD, Moffitt Cancer Center, discussed the trial's impact and the future role of MRD monitoring in treatment ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Cuts to Medicare physician reimbursement have taken effect, as proposed legislation intended to eliminate those cuts did not pass.

Mural nominated two new development candidates, MURA-8518 a novel binding protein-resistant IL-18 with half-life extension, ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

However, Mr Jervis only received a course of antibiotics some 20 hours after it was noted that he needed the medication. Mr ...

The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response ...

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...